Shared Gene Mutations Found in Cancer and Alzheimer's, Revealing New Dementia Mechanism

A new study suggests a surprising link between cancer and Alzheimer's disease, potentially offering new avenues for diagnosis and treatment. Researchers found that gene mutations previously associated with blood cancers like leukemia and lymphoma also appear in the brain cells of Alzheimer's patients.

These mutated immune cells may migrate from the bloodstream into the brain, especially as the blood-brain barrier weakens with age. Once inside, they could proliferate, causing inflammation and damaging surrounding nerve cells, thus contributing to the development of dementia. This discovery challenges the traditional view of Alzheimer's as solely a neurodegenerative disease.

“

Alzheimer's disease has similarities to cancer in some respects, as both involve specific gene mutations.

Scientists at Boston Children's Hospital, who led the research published in the journal Cell, compared brain tissue from Alzheimer's patients and healthy individuals. They observed a higher accumulation of specific gene mutations in the immune cells within the brains of patients. Crucially, they also found these mutations in immune cells circulating in the patients' blood.

This finding opens up possibilities for new diagnostic tools. Researchers suggest that blood tests detecting these specific mutations could potentially evaluate an individual's risk of developing dementia in the future. Furthermore, the study hints at the potential repurposing of certain cancer drugs for Alzheimer's treatment, although researchers emphasize that more studies are needed to confirm a direct causal link and the efficacy of such treatments.

“

These mutated immune cells may enter the brain, triggering inflammatory responses and damaging nerve cells, becoming a new clue to dementia formation.